Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data.
The Lancet Oncology.
Times cited: 56
CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer.
Times cited: 70